All Articles by Author:

Bob

Integration of an Anellovirus Genome in the SKNO-1 Acute Myeloid Leukemia Cell Line

[Microbiology Spectrum] Researchers identified a stably integrated and transcriptionally active anellovirus genome in anAML cell line, providing a unique model to study viral persistence in hematopoietic cells.

CD55 Promotes Hematopoietic Stem and Progenitor Cell Survival in a Mouse Model of Immune-Mediated Aplastic Anaemia

[Blood Advances] Scientists showed that CD55 protects hematopoietic stem and progenitor cells from complement-mediated damage in aplastic anemia, highlighting complement inhibition as a potential therapeutic strategy

The Fanconi Anemia Pathway Restrains MLL-Rearranged Leukemogenesis through Suppressing Non-Homologous End Joining-Mediated Genomic Instability

[Nature Communications] Using murine models and human mixed lineage leukemia (MLL)-r leukemia cells, the authors showed that the FA pathway suppresses leukemogenesis by limiting error-prone non-homologous end joining-mediated genomic instability.

Inhibition of Nucleoporin 214 Depletes Leukemia Stem Cells by Promoting Heme Catabolism and Lipid Peroxidation

[Blood] By screening the nucleoporin (NUP) family, scientists identified NUP214 as a frequently overexpressed gene and a critical fitness determinant in leukemia stem cells (LSCs). NUP214 acts as a conserved driver of LSC survival by restricting heme catabolism, limiting Fe²⁺ accumulation, and suppressing lipid peroxidation.

PTBP1 Controls Oncogenic Transcript Processing and Maintenance of Acute Myeloid Leukemia

[Leukemia] Researchers identified the RNA splicing factor PTBP1 as a key dependency in acute myeloid leukemia, sustaining leukemia by controlling the processing of essential oncogenic transcripts.

Single-Cell Architecture of Purinergic Signaling in Human Cord Blood Hematopoietic Stem and Progenitor Cells

[Leukemia] Investigators mapped purinergic signaling at single-cell resolution in human cord blood stem and progenitor cells, revealing how ATP and adenosine pathways are organized across early blood cell development.

Popular

Challenges and Opportunities in Combining Radiotherapy and Immunotherapy for Localized Pancreatic Cancer

[Nature Reviews Gastroenterology & Hepatology] Expanding preclinical and clinical literature from PDAC and other oncological indications identifies novel approaches through which radiation therapy–immunotherapy combinations could improve local and systemic disease control in patients with PDAC.

Developmental and MAPK-Responsive Transcription Factors Regulate Distinct Malignant Cell States and Associated Genetic Dependencies in Pancreatic Cancer

[Nature Genetics] Single-cell master regulator analysis of multiple pancreatic ductal adenocarcinoma cohorts identified malignant cells in three co-existing, molecularly distinct developmental lineage states, with distinct histopathological morphologies and spatial architecture.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

[US FDA] The US FDA approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.